US sees no problem with Pfizer, Sanofi vaccines
Washington, March 8, 2011
US health agencies "have not detected new safety concerns or unusual reporting patterns" in children given Pfizer or Sanofi Aventis vaccines to prevent meningitis and pneumonia, a Food and Drug Administration spokeswoman said.
The FDA and the Centers for Disease Control and Prevention are aware of the death of four children in Japan that prompted authorities there to halt use of Pfizer's Prevenar and Sanofi's ActHIB, FDA spokeswoman Shelly Burgess said in an emailed statement. The US agencies will continue to monitor the vaccines for safety in the US, she added. – Reuters
More Health & Environment Stories
- NCDs ‘to cost GCC $36bn in 2013’
- Arabtec inks $1.2bn UAE hospital contract
- Infectious disease control ‘urgent need for GCC’
- New HIV cases fall as Bahrain's efforts pay off
- Conference to discuss emergency medicine
- UAE reports 3 more MERS cases
- Bahrain 'free of Mers coronavirus'
- 500,000 suffer from spinal cord injuries
- 3BL to assess Majaal corporate sustainability
- Diabetes experts to meet in Abu Dhabi